Orchid Pharma Q4 Results
- BSE: 524372
- NSE: ORCHPHARMA
- ISIN: INE191A01027
- Sector: Biotechnology & Drugs
BSE
702.00
-15.15 (-2.11%)
-15.15 (-2.11%)Volume2.55 K
Updated: Thu 21 May, 2026 | 15:29:56
NSE
704-11.30 (-1.58%)
-11.30 (-1.58%)Volume29.34 K
Updated: Thu 21 May, 2026 | 15:30:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Orchid Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 218.37 | 221.85 | 9.41% | 195.69 | 11.59% |
| Depreciation/ Amortization | 8.87 | 9.03 | 3.10% | 8.42 | 5.36% |
| Operating Income | 19.11 | -14.58 | 7.63% | 21.41 | -10.73% |
| Net Income | 22.29 | -12.61 | 7.31% | 33.53 | -33.50% |
| Other Operating Expenses Total | 49.24 | 38.43 | 11.57% | 42.43 | 16.04% |
| Net Income Before Taxes | 19.09 | -12.15 | -14.95% | 30.95 | -38.31% |
| Total Revenue | 237.48 | 207.27 | 9.26% | 217.10 | 9.39% |
| Selling/ General/ Admin Expenses Total | 22.24 | 24.13 | 0.83% | 16.72 | 33.02% |
| Diluted Normalized EPS | 4.40 | -1.09 | 7.28% | 6.62 | -33.53% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.